Identifícate
Grupos
Investigadores/as
Financiamento
Resultados
Julen
Oyarzabal Santamarina
Investigador ata 2018
University of Texas Southwestern Medical Center
Dallas, Estados Unidos
Estás en
Colaboracións
University of Texas Southwestern Medical Center
Publicacións en colaboración con investigadores/as de University of Texas Southwestern Medical Center (2)
2024
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
Contactar
Aviso legal
Axuda
translate
gl
arrow_drop_down
translate
gl
arrow_drop_down
es
ca
eu
en
fr
de